VYNE Therapeutics Inc.(VYNE)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

VYNE VYNE Therapeutics Inc.

未开盘 04-30 16:00:00 EDT

0.6367

+0.0008

+0.13%

盘后0.6367

+0.00000.00%

16:54 EDT

最高0.6483	最低0.6220	成交量3.76万
今开0.6220	昨收0.6359	日振幅4.14%
总市值2,119万	流通市值1,963万	总股本3,329万
成交额2.40万	换手率0.12%	流通股本3,082万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"VYNE","market":"US","secType":"STK","nameCN":"VYNE Therapeutics Inc.","latestPrice":0.6367,"timestamp":1777579200000,"preClose":0.6359,"halted":0,"volume":37563,"hourTrading":{"tag":"盘后","latestPrice":0.6367,"preClose":0.6367,"latestTime":"16:54 EDT","volume":213,"amount":135.6164,"timestamp":1777582445274,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.0012580594433087323,"floatShares":30823100,"shares":33286422,"eps":-0.619224,"marketStatus":"未开盘","change":0.0008,"latestTime":"04-30 16:00:00 EDT","open":0.622,"high":0.6483,"low":0.622,"amount":24002.753243699997,"amplitude":0.041359,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.619224,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1777622400000},"marketStatusCode":0,"adr":0,"listingDate":1516856400000,"exchange":"NASDAQ","adjPreClose":0.6359,"preHourTrading":{"tag":"盘前","latestPrice":0.64,"preClose":0.6359,"latestTime":"07:38 EDT","volume":10,"amount":6.4,"timestamp":1777549112176,"change":0.0041,"changeRate":0.006448,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":0.6367,"preClose":0.6367,"latestTime":"16:54 EDT","volume":213,"amount":135.6164,"timestamp":1777582445274,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.671089,"impliedVol":3.8705,"impliedVolPercentile":0},"requestUrl":"/m/hq/s/VYNE","defaultTab":"news","newsList":[{"id":"1188319037","title":"VYNE Therapeutics 第三季度收入为 16.9 万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1188319037","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1188319037?lang=zh_cn&edition=full","pubTime":"2025-11-20 00:59","pubTimestamp":1763571588,"startTime":"0","endTime":"0","summary":"11月6日——VYNE Therapeutics 第三季度净收入为 -728 万美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VYNE","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2581090553","title":"Vyne Therapeutics Inc.盘中异动 急速上涨5.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2581090553","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581090553?lang=zh_cn&edition=full","pubTime":"2025-11-06 01:22","pubTimestamp":1762363365,"startTime":"0","endTime":"0","summary":"北京时间2025年11月06日01时22分，Vyne Therapeutics Inc.股票出现波动，股价快速上涨5.31%。截至发稿，该股报0.345美元/股，成交量29.2393万股，换手率1.15%，振幅6.11%。Vyne Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为1.21%。Vyne Therapeutics Inc.公司简介：VYNE Therapeutics Inc 是一家生物制药公司，专注于开发用于治疗免疫炎症的专有、创新和差异化疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025110601224697563c3c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025110601224697563c3c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VYNE","BK4139","BK4007","BK4539","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518744289","title":"Vyne Therapeutics Inc.2024财年实现净利润-39.81百万美元，同比减少42.84%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518744289","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518744289?lang=zh_cn&edition=full","pubTime":"2025-03-10 00:01","pubTimestamp":1741536074,"startTime":"0","endTime":"0","summary":"3月10日，Vyne Therapeutics Inc.公布财报，公告显示公司2024财年净利润为-39.81百万美元，同比减少42.84%；其中营业收入为501000.00美元，同比增加18.16%，每股基本收益为-0.93美元。从资产负债表来看，Vyne Therapeutics Inc.总负债14.82百万美元，其中短期债务99000.00美元，资产负债比为4.52，流动比率为4.35。机构评级：截至2025年3月10日，当前有4家机构对Vyne Therapeutics Inc.目标价做出预测，其中目标均价为6.19美元，其中最低目标价为5.00美元，最高目标价为8.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310000222abf17562&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310000222abf17562&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VYNE","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1102225461","title":"VYNE Therapeutics 2024年第四季度GAAP每股收益$(0.28) 超预期$(0.30)，销售额$84,000K 未达$140,000K预期","url":"https://stock-news.laohu8.com/highlight/detail?id=1102225461","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1102225461?lang=zh_cn&edition=full","pubTime":"2025-03-06 21:18","pubTimestamp":1741267091,"startTime":"0","endTime":"0","summary":"VYNE Therapeutics(LENZ) 2024年第四季度GAAP每股收益$(0.28) 超预期$(0.30)，销售额$84,000K 未达$140,000K预期。以上内容来自Benzinga Earnings专栏，原文如下：VYNE $Therapeutics(LENZ)$ Q4 2024 GAAP EPS $(0.28) Beats $(0.30) Estimate, Sales $84.000K Miss $140.000K Estimate","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"VYNE Therapeutics 2024年第四季度GAAP每股收益$(0.28) 超预期$(0.30)，销售额$84,000K 未达$140,000K预期","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VYNE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517948564","title":"Vyne Therapeutics Inc.盘中异动 股价大涨5.63%报2.44美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517948564","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517948564?lang=zh_cn&edition=full","pubTime":"2025-03-05 22:37","pubTimestamp":1741185469,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日22时37分，Vyne Therapeutics Inc.股票出现异动，股价大幅拉升5.63%。截至发稿，该股报2.44美元/股，成交量186股，换手率0.00%，振幅0.00%。Vyne Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.63%。Vyne Therapeutics Inc.公司简介：VYNE Therapeutics Inc 是一家生物制药公司，专注于开发专有的、创新的和差异化的治疗免疫炎症的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305223749a260c9b4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305223749a260c9b4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","VYNE","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514777869","title":"Vyne Therapeutics Inc.盘中异动 快速下跌5.66%报2.50美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514777869","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514777869?lang=zh_cn&edition=full","pubTime":"2025-02-27 02:58","pubTimestamp":1740596333,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日02时58分，Vyne Therapeutics Inc.股票出现异动，股价急速下跌5.66%。截至发稿，该股报2.50美元/股，成交量4.4581万股，换手率0.30%，振幅6.98%。Vyne Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为0.74%。Vyne Therapeutics Inc.公司简介：VYNE Therapeutics Inc 是一家生物制药公司，专注于开发专有的、创新的和差异化的治疗免疫炎症的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227025853abde2799&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227025853abde2799&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VYNE","LENZ","BK4007","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2505019778","title":"Vyne Therapeutics Inc.盘中异动 股价大涨6.62%","url":"https://stock-news.laohu8.com/highlight/detail?id=2505019778","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505019778?lang=zh_cn&edition=full","pubTime":"2025-01-23 22:31","pubTimestamp":1737642680,"startTime":"0","endTime":"0","summary":"北京时间2025年01月23日22时31分，Vyne Therapeutics Inc.股票出现异动，股价大幅拉升6.62%。截至发稿，该股报2.90美元/股，成交量1179股，换手率0.01%，振幅0.00%。Vyne Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.02%。Vyne Therapeutics Inc.公司简介：VYNE Therapeutics Inc 是一家生物制药公司，专注于开发专有的、创新的和差异化的治疗免疫炎症的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250123223121960e43da&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250123223121960e43da&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4007","VYNE","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2504162922","title":"Vyne Therapeutics Inc.盘中异动 股价大涨9.30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2504162922","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2504162922?lang=zh_cn&edition=full","pubTime":"2025-01-17 22:31","pubTimestamp":1737124312,"startTime":"0","endTime":"0","summary":"北京时间2025年01月17日22时31分，Vyne Therapeutics Inc.股票出现波动，股价大幅拉升9.30%。截至发稿，该股报2.82美元/股，成交量9917股，换手率0.07%，振幅0.00%。Vyne Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.73%。Vyne Therapeutics Inc.公司简介：VYNE Therapeutics Inc 是一家生物制药公司，专注于开发专有的、创新的和差异化的治疗免疫炎症的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250117223152abaeb08f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250117223152abaeb08f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","VYNE","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2503642074","title":"Vyne Therapeutics Inc.盘中异动 早盘快速拉升5.09%报2.89美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2503642074","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503642074?lang=zh_cn&edition=full","pubTime":"2025-01-15 22:31","pubTimestamp":1736951465,"startTime":"0","endTime":"0","summary":"北京时间2025年01月15日22时31分，Vyne Therapeutics Inc.股票出现异动，股价快速拉升5.09%。截至发稿，该股报2.89美元/股，成交量2559股，换手率0.02%，振幅0.00%。Vyne Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.68%。其相关个股中，Os Therapies Incorporated、Exicure, Inc.、Eterna Therapeutics Inc.涨幅较大，Windtree Therapeutics, Inc.、Os Therapies Incorporated、Phio Pharmaceuticals Corp.较为活跃，换手率分别为183.55%、55.23%、50.88%，振幅较大的相关个股有Vincerx Pharma, Inc.、Onconetix, Inc.、Viracta Therapeutics, Inc.，振幅分别为10.72%、9.31%、9.18%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025011522310698673ab8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025011522310698673ab8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","VYNE","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2489237536","title":"Vyne Therapeutics Inc.盘中异动 早盘急速拉升6.25%报2.72美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2489237536","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489237536?lang=zh_cn&edition=full","pubTime":"2024-12-06 23:41","pubTimestamp":1733499668,"startTime":"0","endTime":"0","summary":"北京时间2024年12月06日23时41分，Vyne Therapeutics Inc.股票出现异动，股价快速上涨6.25%。截至发稿，该股报2.72美元/股，成交量1.3495万股，换手率0.09%，振幅3.52%。Vyne Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.70%。Vyne Therapeutics Inc.公司简介：VYNE Therapeutics Inc 是一家生物制药公司，专注于开发专有的、创新的和差异化的治疗免疫炎症的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241206234108ab62f961&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241206234108ab62f961&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4139","LENZ","VYNE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2485141068","title":"Vyne Therapeutics Inc.盘中异动 快速拉升5.86%","url":"https://stock-news.laohu8.com/highlight/detail?id=2485141068","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485141068?lang=zh_cn&edition=full","pubTime":"2024-11-21 00:27","pubTimestamp":1732120038,"startTime":"0","endTime":"0","summary":"北京时间2024年11月21日00时27分，Vyne Therapeutics Inc.股票出现异动，股价急速上涨5.86%。截至发稿，该股报2.89美元/股，成交量3.4354万股，换手率0.23%，振幅3.98%。Vyne Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.56%。Vyne Therapeutics Inc.公司简介：VYNE Therapeutics Inc 是一家生物制药公司，专注于开发专有的、创新的和差异化的治疗免疫炎症的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112100271898e43c6c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112100271898e43c6c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VYNE","BK4007","BK4139","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2484967568","title":"Vyne Therapeutics Inc.盘中异动 早盘股价大涨5.19%报2.84美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2484967568","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484967568?lang=zh_cn&edition=full","pubTime":"2024-11-18 22:31","pubTimestamp":1731940283,"startTime":"0","endTime":"0","summary":"北京时间2024年11月18日22时31分，Vyne Therapeutics Inc.股票出现异动，股价大幅上涨5.19%。截至发稿，该股报2.84美元/股，成交量2329股，换手率0.02%，振幅0.00%。Vyne Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为0.22%。Vyne Therapeutics Inc.公司简介：VYNE Therapeutics Inc 是一家生物制药公司，专注于开发专有的、创新的和差异化的治疗免疫炎症的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111822312395be481f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111822312395be481f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4007","VYNE","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2483309815","title":"Vyne Therapeutics Inc.2024财年第三财季实现净利润-12.16百万美元，同比减少100.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483309815","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483309815?lang=zh_cn&edition=full","pubTime":"2024-11-16 00:00","pubTimestamp":1731686437,"startTime":"0","endTime":"0","summary":"11月16日，Vyne Therapeutics Inc.公布财报，公告显示公司2024财年第三财季净利润为-12.16百万美元，同比减少100.33%；其中营业收入为121000.00美元，同比增加6.14%，每股基本收益为-0.29美元。从资产负债表来看，Vyne Therapeutics Inc.总负债12.66百万美元，其中短期债务123000.00美元，资产负债比为6.02，流动比率为5.81。机构评级：截至2024年11月16日，当前有3家机构对Vyne Therapeutics Inc.目标价做出预测，其中目标均价为5.58美元，其中最低目标价为5.00美元，最高目标价为6.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241116000345a23b8a11&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241116000345a23b8a11&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VYNE","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2481318445","title":"Vyne Therapeutics Inc.盘中异动 早盘快速拉升5.11%报3.29美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2481318445","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481318445?lang=zh_cn&edition=full","pubTime":"2024-11-07 23:07","pubTimestamp":1730992021,"startTime":"0","endTime":"0","summary":"北京时间2024年11月07日23时07分，Vyne Therapeutics Inc.股票出现异动，股价急速上涨5.11%。截至发稿，该股报3.29美元/股，成交量1.802万股，换手率0.12%，振幅3.83%。Vyne Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.07%。Vyne Therapeutics Inc.公司简介：VYNE Therapeutics Inc 是一家生物制药公司，专注于开发专有的、创新的和差异化的治疗免疫炎症的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110723070198e41396&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110723070198e41396&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VYNE","LENZ","BK4139","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2480587999","title":"Vyne Therapeutics Inc.盘中异动 快速上涨6.41%报2.82美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2480587999","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480587999?lang=zh_cn&edition=full","pubTime":"2024-11-04 23:20","pubTimestamp":1730733631,"startTime":"0","endTime":"0","summary":"北京时间2024年11月04日23时20分，Vyne Therapeutics Inc.股票出现异动，股价急速上涨6.41%。截至发稿，该股报2.82美元/股，成交量3.6402万股，换手率0.25%，振幅6.04%。Vyne Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.01%。Vyne Therapeutics Inc.公司简介：VYNE Therapeutics Inc 是一家生物制药公司，专注于开发专有的、创新的和差异化的治疗免疫炎症的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241104232031ab9ed43d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241104232031ab9ed43d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","VYNE","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2467977341","title":"Vyne Therapeutics Inc.盘中异动 快速拉升10.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2467977341","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2467977341?lang=zh_cn&edition=full","pubTime":"2024-09-13 21:37","pubTimestamp":1726234620,"startTime":"0","endTime":"0","summary":"北京时间2024年09月13日21时37分，Vyne Therapeutics Inc.股票出现波动，股价快速上涨10.06%。截至发稿，该股报1.97美元/股，成交量383股，换手率0.00%，振幅0.00%。Vyne Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.21%。其相关个股中，Immuneering Corporation、Syros Pharmaceuticals, Inc.、Instil Bio, Inc.涨幅较大，Windtree Therapeutics, Inc.、Immuneering Corporation、Galmed Pharmaceuticals Ltd.较为活跃，换手率分别为682.69%、69.15%、68.33%，振幅较大的相关个股有Syros Pharmaceuticals, Inc.、Oramed Pharmaceuticals Inc.、Immuneering Corporation，振幅分别为21.63%、16.10%、16.08%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240913213700956323c5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240913213700956323c5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","VYNE","LENZ","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.vynetherapeutics.com","stockEarnings":[{"period":"1week","weight":-0.0055},{"period":"1month","weight":0.0656},{"period":"3month","weight":0.1247},{"period":"6month","weight":0.79},{"period":"1year","weight":-0.5213},{"period":"ytd","weight":0.0976}],"compareEarnings":[{"period":"1week","weight":0.0144},{"period":"1month","weight":0.1051},{"period":"3month","weight":0.0386},{"period":"6month","weight":0.0537},{"period":"1year","weight":0.296},{"period":"ytd","weight":0.0539}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"VYNE Therapeutics Inc.于2011年10月作为特拉华州的一家公司注册成立，最初名为Tigercat Pharma，Inc。该公司是一家临床阶段的生物制药公司，专注于开发针对具有重大未满足需求的炎症和免疫介导疾病的差异化疗法。该公司拥有从Tay Therapeutics Ltd获得许可的研究、开发和商业化小分子溴结构域和末端外结构域（BET）抑制剂的全球独家权利。该公司针对免疫介导的炎症性疾病，重点是目前尚未由其他公司开发的新型BET抑制剂。","yearOnYearQuotes":[{"month":1,"riseRate":0.375,"avgChangeRate":0.037101},{"month":2,"riseRate":0.444444,"avgChangeRate":0.014686},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.004341},{"month":4,"riseRate":0.222222,"avgChangeRate":-0.154087},{"month":5,"riseRate":0.5,"avgChangeRate":-0.002439},{"month":6,"riseRate":0.125,"avgChangeRate":-0.051065},{"month":7,"riseRate":0.375,"avgChangeRate":-0.153902},{"month":8,"riseRate":0.125,"avgChangeRate":-0.085706},{"month":9,"riseRate":0.5,"avgChangeRate":-0.023153},{"month":10,"riseRate":0.5,"avgChangeRate":0.011012},{"month":11,"riseRate":0.5,"avgChangeRate":-0.029442},{"month":12,"riseRate":0.375,"avgChangeRate":-0.029662}],"exchange":"NASDAQ","name":"VYNE Therapeutics Inc.","nameEN":"VYNE Therapeutics Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.1","shortVersion":"4.42.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"VYNE Therapeutics Inc.(VYNE)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供VYNE Therapeutics Inc.(VYNE)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"VYNE Therapeutics Inc.,VYNE,VYNE Therapeutics Inc.股票,VYNE Therapeutics Inc.股票老虎,VYNE Therapeutics Inc.股票老虎国际,VYNE Therapeutics Inc.行情,VYNE Therapeutics Inc.股票行情,VYNE Therapeutics Inc.股价,VYNE Therapeutics Inc.股市,VYNE Therapeutics Inc.股票价格,VYNE Therapeutics Inc.股票交易,VYNE Therapeutics Inc.股票购买,VYNE Therapeutics Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"VYNE Therapeutics Inc.(VYNE)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供VYNE Therapeutics Inc.(VYNE)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}